Funding

CURRENT FUNDING

1 R03 HS026819- 01A1 (McGregor): 9/01/2019 – 8/31/2020
AHRQ
Evaluating antibiotic utilization metrics
Study aims to evaluate the CDC’s risk adjusted SAAR metric as a proxy for appropriate use of antibacterials.
Role: PI


IIR 17-039 (Suda): 7/01/2018 – 6/30/2022
VA HSR&D
Optimizing antibiotic prescribing on discharge to long-term care facilities
Study aims to identify opportunities for prescribing intervention and to understand the facilitators and barriers to implementing these interventions in acute care and long term care facilities.
Role: Co-Investigator


1 R01 HS026747- 01A1 (Furuno): 2/01/2019 – 1/31/2022
AHRQ
Optimizing antibiotic prescribing on discharge to long-term care facilities
Study aims to identify opportunities for prescribing intervention and to understand the facilitators and barriers to implementing these interventions in acute care and long term care facilities.
Role: Co-Investigator


1R01HS02517701A1 (Suda): 09/30/17-01/07/21
AHRQ
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
Role: Co-Investigator


SMMI0235A, (Helfand): 01/01/16-12/31/21
PCORI
Peer Review of PCORI’s Funded Research
Contract provides infrastructure for the peer review and ultimate publication of final reports from all PCORI-funded contracts.
Role: Associate Editor


PAST FUNDING


 

1 R01 HS022706 – 01A1 (McGregor): 9/30/2014 – 9/29/2018
AHRQ
Improving empiric therapy in ambulatory care
Study aims to develop risk score that can inform prudent and appropriate antibiotic selection for uncomplicated urinary tract infections in primary care settings
Role: Co-Investigator


000HCVLD-2016-03606 (Pakyz): 09/30/16-09/29/19
Centers for Disease Control and Prevention
Development of NHSN’s AUR data and SAAR to support Antibiotic Benchmarking Program among Vizient Members.
Role: Consortium PI


IFRA-0281 (Furuno): 01/06/17-01/06/19
Merck Sharp & Dohme Corp.
A Retrospective Cohort Study of the Benefits and Burdens of Preemptive Antiviral Therapy for CMV among Hematopoietic Stem Cell Transplant Patients
Role: Co-Investigator


HC-1510-06870 (Hartung): 10/01/16-09/30/18
National Multiple Sclerosis Society
Costs, Access, and Value of Multiple Sclerosis Disease-Modifying Therapies
Evidence generated from this study can be used by NMSS and other MS stakeholders better advocate for policies to mitigate problems associated with the high costs of DMTs in the US.
Role: Co-Investigator


 

Un-numbered (Tallman): 10/01/17-09/30/18
Society for Infectious Diseases Pharmacists
Epidemiology of Recurrent UTI in Female Outpatients
Role: Mentor/Co-Investigator